Skip to main navigation
Skip to search
Skip to main content
Sort by
Chemistry
Ring Expansion
100%
Aziridine
87%
Occurrence in Nature
77%
Oxirane
61%
Heterocyclic Compound
50%
Structure
39%
Organic Chemistry
34%
Ring Formation
29%
Phase Composition
29%
Primary Structure
27%
Phenol
27%
Oxetane
26%
Nucleophile
24%
Diterpenoid
23%
Vulcanization
23%
Chemistry
23%
Rearomatization
23%
Radical Cyclization
23%
Diels-Alder Intramolecular Cycloaddition
23%
Migrastatin
23%
Wharton Fragmentation
23%
Rhodium
23%
Imine
20%
3-Pyrroline
19%
Heteroatom
17%
NMR Spectroscopy
17%
Alkene
17%
Thiophosphate
17%
Cope Rearrangement
17%
Diastereomer
15%
Kinetic Study
15%
Lewis Acid
14%
Counterion
14%
Ring Opening Reaction
14%
Diels-Alder Reaction
14%
Fluorine
13%
Cyclopropane
13%
Cyclohexenone
13%
Transition State
13%
Sulfur Atom
11%
Catechol
11%
Ambient Reaction Temperature
11%
Indole
11%
Adler Phenol Oxidation
11%
Enantiomer
11%
Platensimycin
11%
Thiirane
11%
Transition Element
11%
Chemical Element
11%
Cyclic Structure
11%
Keyphrases
Ring Expansion
58%
Total Synthesis
46%
Vinylaziridines
34%
Copper-catalyzed
34%
Migrastatin
34%
Synthetic Approaches
34%
Ring-expansion Reaction
27%
Natural Products
26%
Thiirane
23%
Sulfenyl Chloride
23%
Vinyloxirane
23%
Inverse Vulcanization
23%
Vinigrol
23%
Aziridine
23%
3-Pyrrolines
20%
Imines
19%
Sulfur Monochloride
17%
Maoecrystal V
17%
Annulation
17%
Rearomatization
15%
Vinyl
15%
Darzens Reaction
15%
Nucleophile
15%
Vinylogous
15%
Carbocyclic
15%
Aldehydes
15%
Cyclization
13%
Recent Advances
13%
Organic Chemistry
13%
Phenolic Oxidation
11%
Green Book
11%
Veterinary Drugs
11%
Allenyl
11%
Platensimycin
11%
Creative Approach
11%
Base-mediated
11%
Trifluoroethyl Ether
11%
N-sulfinyl Imines
11%
Amino
11%
Selective Ring Opening
11%
Tandem Radical Cyclization
11%
Isotwistane
11%
Structure-activity Studies
11%
Aza-Darzens
11%
Dihydrobenzofuran
11%
Ring Width
11%
Graphical Presentation
11%
Ring Systems
11%
Chiral Counteranions
11%
National Science Foundation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
38%
Natural Product
34%
Sulfur
34%
Disease
28%
Carbon Nanotube
23%
Neoplasm
23%
Mouse
23%
Malignant Neoplasm
22%
Pyrimidine
11%
Diterpenoid
11%
2,5-Dimethoxy-4-iodoamphetamine
11%
Piperidine
11%
Morpholine
11%
Cantharidin
11%
Drug Discovery
11%
Breast Tumor
11%
Apple
11%
Glutarimide
11%
Metastasis
11%
Lung Cancer
11%
Benzofuran
11%
Lead(IV) Acetate
11%
Combination Drug
11%
Drug Development
11%
Fascin
11%
Pyrazole
11%
Phenol
11%
Yttrium 86
11%
Veterinary Drug
11%
Ether Derivative
9%
Morpholine Derivative
5%
1,3 Dioxolane Derivative
5%
Drug Analysis
5%